Parity Pharma ApS
CVR 45346951 · Private limited company (ApS) · Active · Very high risk
Parity Pharma ApS is a Private limited company (ApS), founded on , based in København K. The company is registered in the industry engroshandel med medicinalvarer og sygeplejeartikler. Our model estimates a bankruptcy risk of 9.4% over the next 12 months, which is 6.7 times the average for Danish companies. 1 annual report has been published. The latest annual report (31 Dec 2025) shows equity of DKK 58k and a net result of DKK 18k. CEO: Simon James Dorris.
Bankruptcy risk for Parity Pharma ApS
6.7 × the average (1.41%) · higher risk than 97% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 45346951
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (1 years)
- Address
- Rådhusstræde 15
1466 København K - Municipality
- København
- Industry
- Engroshandel med medicinalvarer og sygeplejeartikler (464610)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr - Share capital
- DKK 40k
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 1 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 13.1% |
| Current ratio | 115% |
| Moves (last 2 years) | 1 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 303 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 |
|---|---|
| Gross profit | DKK 24k |
| Net profit | DKK 18k |
| Equity | DKK 58k |
| Total assets | DKK 445k |
| Cash | DKK 167k |
| Short-term debt | DKK 387k |
| Tax owed | DKK 5,302 |
| Avg. employees | 1 |
Latest annual report: Reporting class B · auditor's statement: No assurance.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 20 Jan 2025 – 31 Dec 2025 | 168 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Simon James Dorris | Current | |
| Owner (100%) | ASPRITA LIMITED | Current | |
| Owner (100%) | Lansdowne Consulting Limited | ||
| Founder | Lansdowne Consulting Limited | Current |
Address history (1 moves)
| Rådhusstræde 15, 1466 København K | |
| c/o Bird & Bird Advokatpartnerselskab, Kalkbrænderiløbskaj 8, st., 2100 København Ø |
Former names
| Parity Pharma ApS | – now |
| Asprita ApS | – |
Other companies at the same address
- A/S PPHJ NR. 301192 Bankrupt
- AA Byg & Udlejning ApS Bankrupt
- AS Gulve ApS Bankrupt
- ASX 9096 ApS Bankrupt
- ASX 9097 ApS Bankrupt
- ASX 9098 ApS Bankrupt
- ASX 9099 ApS Bankrupt
- AY INVEST AF 1992 ApS Bankrupt
- ApS KLL NR. 220393 Bankrupt
- BELUCA FINANS ApS Bankrupt
- BW INVEST AF 1992 ApS Bankrupt
- CENTRA FINANS AF 04.02. 1993 ApS Bankrupt
- CENTRA FINANS AF 04.05.1993. ApS Bankrupt
- CENTRA FINANS AF 18.05.93 3 ApS Bankrupt
- CENTRA FINANS AF 18.05.93. 2 A/S Bankrupt
- CENTRA FINANS AF 18.05.93. 4 ApS Bankrupt
- CENTRA FINANS AF 18.05.93. 5 ApS Bankrupt
- CENTRA FINANS AF 19.03.1993 ApS Bankrupt
- CENTRA FINANS AF 23.06.1993 ApS Bankrupt
- CENTRA FINANS AF 28.01.93 ApS Bankrupt
- CENTRA FINANS AF 29.03.1993 ApS Bankrupt
- CENTRA FINANS AF 29.04.1993 ApS Bankrupt
- CENTRA FINANS AF 30.04.1993 ApS Bankrupt
- CENTRA INVEST AF 23. JUNI 1993 A/S Bankrupt
- DELTA FINANS AF 05.03.93. ApS Bankrupt
Similar companies in København
- ALFASCAN ApS København K
- LUNDBECK PHARMA A/S Valby
- ASTRAZENECA A/S København V
- Sundvik ApS Vanløse
- DEXCOM DENMARK, ApS København Ø
- Nitrilehandsker.dk ApS Valby
- DePuy Synthes (Denmark) ApS København K
- ELSE NORDICS APS København S
- MSD Animal Health A/S København V
- DentFriends ApS København S
- Sanad Health ApS København N
- Venteus Medical Devices (ROW) ApS København Ø
Questions and answers about Parity Pharma ApS
Has Parity Pharma ApS gone bankrupt?
No, Parity Pharma ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Parity Pharma ApS?
Our model estimates a bankruptcy risk of 9.4% over the next 12 months (very high risk), which is 6.7 times the average for Danish companies.
Who is the CEO of Parity Pharma ApS?
Simon James Dorris is the CEO of Parity Pharma ApS.
When was Parity Pharma ApS founded?
Parity Pharma ApS was founded on 20 January 2025.
What is the equity of Parity Pharma ApS?
Equity was DKK 58k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.